Search research articles
Contact Us
Filters
Showing results (361-370 of 380) with videos related to
Page
of 38
Sort By:
BMC Musculoskeletal Disorders
|
January 30, 2007
Managing Injuries of the Neck Trial (MINT): design of a randomised controlled trial of treatments for whiplash associated disorders
Sarah E Lamb, Simon Gates, Martin R Underwood, et al.
Journal of Clinical Periodontology
|
January 31, 2006
Effect of rhPDGF-BB on bone turnover during periodontal repair
David P Sarment, Jason W Cooke, Sarah E Miller, et al.
Critical Care Medicine
|
July 18, 2015
The System-Wide Effect of Real-Time Audiovisual Feedback and Postevent Debriefing for In-Hospital Cardiac Arrest: The Cardiopulmonary Resuscitation Quality Improvement Initiative
Keith Couper, Peter K Kimani, Benjamin S Abella, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1995
CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects
T A Rugsley, M D Davis, H C Akunne, et al.
Lancet (London, England)
|
December 25, 2012
Emergency department treatments and physiotherapy for acute whiplash: a pragmatic, two-step, randomised controlled trial
Sarah E Lamb, Simon Gates, Mark A Williams, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2024
Histone H3 N-terminal recognition by the PHD finger of PHRF1 is required for proper DNA damage response
Kanishk Jain, Pata-Eting Kougnassoukou Tchara, Amanuel B Mengistalem, et al.
Physical Review Letters
|
September 26, 2012
Electronic structure changes across the metamagnetic transition in FeRh via hard X-ray photoemission
A X Gray, D W Cooke, P Krüger, et al.
BMJ Open
|
April 13, 2019
The impact of general practitioners working in or alongside emergency departments: a rapid realist review
Alison Cooper, Freya Davies, Michelle Edwards, et al.
Neuropharmacology
|
April 13, 2000
PD 158771, a potential antipsychotic agent with D(2)/D(3) partial agonist and 5-HT(1A) agonist actions. I. Neurochemical effects
H C Akunne, K T Zoski, M D Davis, et al.
Nucleic Acids Research
|
July 17, 2025
Histone H3 N-terminal recognition by the PHD finger of PHRF1 is required for proper DNA damage response
Kanishk Jain, Pata-Eting Kougnassoukou Tchara, Abid Khan, et al.
Page
of 38
Search research articles
Search
Showing results (361-370 of 380) with videos related to
Sort By:
Page
of 38
BMC Musculoskeletal Disorders
|
January 30, 2007
Managing Injuries of the Neck Trial (MINT): design of a randomised controlled trial of treatments for whiplash associated disorders
Sarah E Lamb, Simon Gates, Martin R Underwood, et al.
Journal of Clinical Periodontology
|
January 31, 2006
Effect of rhPDGF-BB on bone turnover during periodontal repair
David P Sarment, Jason W Cooke, Sarah E Miller, et al.
Critical Care Medicine
|
July 18, 2015
The System-Wide Effect of Real-Time Audiovisual Feedback and Postevent Debriefing for In-Hospital Cardiac Arrest: The Cardiopulmonary Resuscitation Quality Improvement Initiative
Keith Couper, Peter K Kimani, Benjamin S Abella, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1995
CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects
T A Rugsley, M D Davis, H C Akunne, et al.
Lancet (London, England)
|
December 25, 2012
Emergency department treatments and physiotherapy for acute whiplash: a pragmatic, two-step, randomised controlled trial
Sarah E Lamb, Simon Gates, Mark A Williams, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2024
Histone H3 N-terminal recognition by the PHD finger of PHRF1 is required for proper DNA damage response
Kanishk Jain, Pata-Eting Kougnassoukou Tchara, Amanuel B Mengistalem, et al.
Physical Review Letters
|
September 26, 2012
Electronic structure changes across the metamagnetic transition in FeRh via hard X-ray photoemission
A X Gray, D W Cooke, P Krüger, et al.
BMJ Open
|
April 13, 2019
The impact of general practitioners working in or alongside emergency departments: a rapid realist review
Alison Cooper, Freya Davies, Michelle Edwards, et al.
Neuropharmacology
|
April 13, 2000
PD 158771, a potential antipsychotic agent with D(2)/D(3) partial agonist and 5-HT(1A) agonist actions. I. Neurochemical effects
H C Akunne, K T Zoski, M D Davis, et al.
Nucleic Acids Research
|
July 17, 2025
Histone H3 N-terminal recognition by the PHD finger of PHRF1 is required for proper DNA damage response
Kanishk Jain, Pata-Eting Kougnassoukou Tchara, Abid Khan, et al.
Page
of 38